Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin

Creative Commons License

AK G., Tada Y., Shimada H., METİNTAŞ S., Ito M., Hiroshima K., ...Daha Fazla

BMC CANCER, cilt.17, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1186/s12885-017-3209-5
  • Dergi Adı: BMC CANCER
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: Mesothelioma, Mesothelin, Midkine, Prognosis, Biomarker, PLEURAL MESOTHELIOMA, SOLUBLE MESOTHELIN, SERUM MESOTHELIN, HYALURONIC-ACID, OSTEOPONTIN, CANCER, BIOMARKER, UTILITY, GROWTH, METAANALYSIS
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Background: We evaluated possible diagnostic and prognostic values of serum midkine in malignant pleural mesothelioma in comparison with those of serum mesothelin, a well-established diagnostic biomarker.